+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Microfluidic Chip in Biomedical Field Market - Global Forecast 2026-2032- Product Image
Microfluidic Chip in Biomedical Field Market - Global Forecast 2026-2032- Product Image
Sale

Microfluidic Chip in Biomedical Field Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6129660
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Microfluidic Chip in Biomedical Field Market is projected to reach USD 1.80 Billion in 2026. It is expected to continue growing at a CAGR of 10.53%, reaching USD 3.28 Billion by 2032.

Microfluidic Chips in Biomedical Applications: Executive Overview

Microfluidic chips integrate miniaturized fluid handling, sensing, preparation, and analysis on compact platforms. In biomedical applications, they support diagnostic testing, cell analysis, drug research, sample preparation, and point-of-care workflows. Their value proposition centers on lower sample and reagent consumption, shorter processing steps, portability, and potential integration with digital analytics. Adoption depends on analytical performance, manufacturing repeatability, clinical validation, workflow compatibility, reimbursement, and regulatory acceptance.

Miniaturization and Workflow Integration Are Reshaping Biomedical Testing

The field is shifting from standalone laboratory components toward integrated workflows that combine sample preparation, fluid manipulation, detection, and result interpretation. This transition is encouraged by demand for decentralized testing, faster turnaround, smaller instruments, and reduced laboratory complexity. Greater use of disposable cartridges, multiplexed assays, automation, and connected devices is also changing product-development priorities. Key barriers remain biological variability, clogging and fouling, difficult scale-up, inconsistent materials performance, and the need to demonstrate reliability across diverse clinical settings.

Artificial Intelligence Strengthens Interpretation, Design, and Operational Control

Artificial intelligence can increase the usefulness of microfluidic biomedical systems by assisting image interpretation, anomaly detection, assay optimization, fluidic control, and experimental design. Machine-learning models may help identify cellular patterns or improve signal classification when paired with sufficiently representative and well-labeled datasets. AI can also support predictive maintenance and quality monitoring in automated platforms. However, dependable deployment requires explainable outputs, strict data governance, bias assessment, cybersecurity, external validation, and clear separation between investigational tools and clinically validated diagnostic decisions.

Regional Dynamics Reflect Different Healthcare, Manufacturing, and Regulatory Conditions

North America benefits from strong biomedical research capacity, advanced diagnostics development, and established clinical-investment networks, while regulatory and reimbursement evidence remains important for commercialization. Europe combines substantial academic expertise with cross-border regulatory considerations and a strong emphasis on laboratory quality, data protection, and health-system integration. Asia-Pacific is supported by expanding biomedical manufacturing, research capabilities, and demand for accessible diagnostics, with adoption patterns varying across healthcare systems. Latin America presents opportunities linked to decentralized testing and public-health needs, but procurement, infrastructure, and regulatory fragmentation can affect implementation. The Middle East is pursuing healthcare modernization and laboratory capability development, while the Africa region emphasizes affordability, portability, supply-chain resilience, and suitability for settings with limited laboratory infrastructure.

Economic and Security Alliances Shape Collaboration and Deployment Priorities

ASEAN economies provide a varied combination of manufacturing capability, growing healthcare demand, and uneven regulatory readiness, making interoperability and workforce training important. BRICS members span major research, industrial, and public-health systems, creating opportunities for technology cooperation alongside differences in standards, procurement, and data governance. The European Union emphasizes harmonized regulatory pathways, quality systems, and cross-border health-data considerations. G7 countries contribute advanced research, clinical development, and high-quality manufacturing ecosystems. GCC markets are investing in healthcare modernization and centralized infrastructure, which can support adoption when local validation and service capacity are addressed. NATO members combine sophisticated biomedical capabilities with heightened interest in resilient supply chains, secure data handling, and continuity of critical healthcare operations.

Country-Level Priorities Range from Research Leadership to Accessible Diagnostics

Australia supports biomedical research and decentralized testing initiatives across geographically dispersed communities. Brazil’s priorities include adaptable diagnostics, public-health deployment, and domestic technical capability. Canada combines strong life-science research with attention to healthcare integration and evidence requirements. China is advancing biomedical engineering, manufacturing, and large-scale clinical application under evolving regulatory frameworks. France, Germany, Italy, and Spain contribute research, medical-device development, and European health-system adoption, with emphasis on validation and quality compliance. India is focused on affordable, scalable diagnostics and locally relevant manufacturing. Japan emphasizes precision engineering, laboratory automation, and high-reliability healthcare technologies. Mexico presents opportunities in nearshore manufacturing and decentralized care, while regulatory and infrastructure conditions remain influential. Russia’s biomedical ecosystem is shaped by domestic capability, supply continuity, and access to specialized technologies. South Korea combines electronics, biotechnology, and advanced manufacturing strengths. The United Kingdom has deep academic and clinical research capabilities, with adoption influenced by evidence generation and health-system procurement. The United States remains a major center for biomedical innovation, clinical translation, and regulatory development, with commercialization dependent on robust performance evidence and workflow fit.

Industry Leaders Should Prioritize Validation, Interoperability, and Responsible Automation

Leaders should begin with clearly defined clinical or laboratory workflows and select applications where reduced sample volume, rapid processing, multiplexing, or portability delivers measurable operational value. Development programs should use representative samples, standardized performance metrics, independent validation, and early consultation with regulators, clinicians, laboratory professionals, and procurement stakeholders. Designs should account for manufacturability, cartridge quality control, supply continuity, instrument maintenance, and operator training from the outset. AI-enabled functions should include documented data provenance, human oversight, cybersecurity controls, and monitoring for performance drift. Partnerships with healthcare providers and local technical organizations can improve implementation, especially in regions with infrastructure constraints.

Methodology: Evidence-Based Synthesis of Technology, Application, and Geography

This executive summary uses the defined market scope of microfluidic chips in biomedical applications and organizes findings across technology development, clinical and laboratory workflows, artificial intelligence, regional conditions, economic groups, and countries. Insights should be substantiated through peer-reviewed literature, regulatory publications, clinical-trial records, standards documents, public-health sources, institutional reports, and documented manufacturing or implementation evidence. Qualitative interpretation should distinguish demonstrated performance from emerging potential and should account for application-specific differences in diagnostics, research, therapeutics, and cell analysis. No unsupported quantitative claims are used.

Reliable Translation Will Determine the Field’s Biomedical Impact

Microfluidic chips are positioned to support more compact, integrated, and responsive biomedical workflows, but technical novelty alone will not ensure adoption. Progress will depend on reproducible manufacturing, clinically meaningful validation, regulatory clarity, interoperable data systems, and sustainable operating models. Regional and country conditions will shape where decentralized and automated applications are most practical. Organizations that connect engineering performance with user needs, evidence quality, responsible AI, and implementation readiness will be best placed to convert microfluidic capabilities into dependable biomedical outcomes.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Microfluidic Chip in Biomedical Field Market, by Throughput
7.1. Introduction
7.2. High Throughput
7.2.1. Standard High
7.2.2. Ultra High
7.3. Low To Moderate Throughput
7.3.1. Analytical
7.3.2. Preparative
8. Microfluidic Chip in Biomedical Field Market, by Technology
8.1. Introduction
8.2. Continuous Flow
8.2.1. Electrokinetic
8.2.2. Pressure-Driven
8.3. Digital Microfluidics
8.3.1. DEP
8.3.2. EWOD
8.4. Droplet-Based
8.4.1. Nanodroplet
8.4.2. Picodroplet
9. Microfluidic Chip in Biomedical Field Market, by Material
9.1. Introduction
9.2. Glass
9.2.1. Borosilicate
9.2.2. Quartz
9.3. Paper
9.3.1. Cellulose
9.3.2. Nitrocellulose
9.4. Polymer
9.4.1. PDMS
9.4.2. Thermoplastics
9.4.3. UV-Curable
9.5. Silicon
9.5.1. Porous
9.5.2. Standard
10. Microfluidic Chip in Biomedical Field Market, by Product Type
10.1. Introduction
10.2. Flow Cytometry Chip
10.3. Lab On A Chip
10.3.1. Controlled Lab Instruments
10.3.2. Point Of Care
10.4. Micro Total Analysis System
10.5. Organ On Chip
11. Microfluidic Chip in Biomedical Field Market, by Application
11.1. Introduction
11.2. Cell Analysis
11.3. Diagnostics
11.3.1. Genetic Testing
11.3.2. Immunoassay
11.3.3. Infectious Disease
11.4. Drug Discovery
11.4.1. ADMET Analysis
11.4.2. High Throughput Screening
11.5. Personalized Medicine
11.5.1. Biomarker Discovery
11.5.2. Genetic Profiling
11.6. Point Of Care Testing
12. Microfluidic Chip in Biomedical Field Market, by End User
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Diagnostic Laboratories
12.4. Hospitals
12.5. Pharmaceutical Companies
12.6. Point Of Care Centers
13. Microfluidic Chip in Biomedical Field Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Microfluidic Chip in Biomedical Field Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Microfluidic Chip in Biomedical Field Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. 10x Genomics, Inc.
17.2. Agilent Technologies, Inc.
17.3. Aline Inc.
17.4. Becton, Dickinson and Company
17.5. Bio-Rad Laboratories, Inc.
17.6. Cherry Biotech SAS
17.7. Danaher Corporation
17.8. Dolomite Microfluidics
17.9. Elveflow (Elvesys)
17.10. Emulate, Inc.
17.11. Fluidic Analytics Ltd.
17.12. Fluidigm Corporation
17.13. Illumina, Inc.
17.14. Merck KGaA
17.15. Micronit Microtechnologies B.V.
17.16. Mimetas B.V.
17.17. Nanostring Technologies, Inc.
17.18. PerkinElmer, Inc.
17.19. Roche Diagnostics International AG
17.20. Sphere Fluidics Limited
17.21. Standard BioTools Inc.
17.22. Thermo Fisher Scientific Inc.
17.23. Zymergen Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Microfluidic Chip in Biomedical Field Market, Years Considered for the Study
FIGURE 2. Global Microfluidic Chip in Biomedical Field Market, Research Design
FIGURE 3. Global Microfluidic Chip in Biomedical Field Market, Research Framework
FIGURE 4. Global Microfluidic Chip in Biomedical Field Market, Data Triangulation
FIGURE 5. Global Microfluidic Chip in Biomedical Field Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Microfluidic Chip in Biomedical Field Market Size, by Throughput, 2025 vs 2032 (%)
FIGURE 7. Global Microfluidic Chip in Biomedical Field Market Size, by Throughput, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Microfluidic Chip in Biomedical Field Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Microfluidic Chip in Biomedical Field Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Microfluidic Chip in Biomedical Field Market Size, by Material, 2025 vs 2032 (%)
FIGURE 11. Global Microfluidic Chip in Biomedical Field Market Size, by Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Microfluidic Chip in Biomedical Field Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 13. Global Microfluidic Chip in Biomedical Field Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Microfluidic Chip in Biomedical Field Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Microfluidic Chip in Biomedical Field Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Microfluidic Chip in Biomedical Field Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Microfluidic Chip in Biomedical Field Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Microfluidic Chip in Biomedical Field Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Microfluidic Chip in Biomedical Field Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Microfluidic Chip in Biomedical Field Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Microfluidic Chip in Biomedical Field Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Microfluidic Chip in Biomedical Field Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Microfluidic Chip in Biomedical Field Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Microfluidic Chip in Biomedical Field Market Segmentation & Coverage
TABLE 2. Global Microfluidic Chip in Biomedical Field Market Size, 2017-2032 (USD Million)
TABLE 3. Global Microfluidic Chip in Biomedical Field Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 4. Global High Throughput Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global High Throughput Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global High Throughput Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Standard High Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Standard High Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Standard High Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Ultra High Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Ultra High Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Ultra High Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Low To Moderate Throughput Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Low To Moderate Throughput Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Low To Moderate Throughput Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Analytical Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Analytical Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Analytical Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Preparative Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Preparative Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Preparative Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Microfluidic Chip in Biomedical Field Market Size, by Technology, 2017-2032 (USD Million)
TABLE 23. Global Continuous Flow Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Continuous Flow Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Continuous Flow Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Electrokinetic Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Electrokinetic Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Electrokinetic Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Pressure-Driven Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Pressure-Driven Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Pressure-Driven Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Digital Microfluidics Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Digital Microfluidics Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Digital Microfluidics Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global DEP Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global DEP Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global DEP Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global EWOD Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global EWOD Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global EWOD Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Droplet-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Droplet-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Droplet-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Nanodroplet Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Nanodroplet Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Nanodroplet Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Picodroplet Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Picodroplet Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Picodroplet Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Microfluidic Chip in Biomedical Field Market Size, by Material, 2017-2032 (USD Million)
TABLE 51. Global Glass Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Glass Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Glass Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Borosilicate Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Borosilicate Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Borosilicate Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Quartz Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Quartz Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Quartz Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Paper Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Paper Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Paper Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Cellulose Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Cellulose Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Cellulose Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Nitrocellulose Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Nitrocellulose Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Nitrocellulose Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global PDMS Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global PDMS Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global PDMS Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Thermoplastics Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Thermoplastics Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Thermoplastics Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global UV-Curable Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global UV-Curable Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global UV-Curable Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Silicon Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Silicon Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Silicon Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Porous Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Porous Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Porous Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Standard Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Standard Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Standard Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Microfluidic Chip in Biomedical Field Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 91. Global Flow Cytometry Chip Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Flow Cytometry Chip Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Flow Cytometry Chip Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Lab On A Chip Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Lab On A Chip Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Lab On A Chip Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Controlled Lab Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Controlled Lab Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Controlled Lab Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Point Of Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Point Of Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Point Of Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Micro Total Analysis System Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Micro Total Analysis System Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Micro Total Analysis System Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Organ On Chip Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Organ On Chip Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Organ On Chip Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Microfluidic Chip in Biomedical Field Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. Global Cell Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Cell Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Cell Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global ADMET Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global ADMET Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global ADMET Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global High Throughput Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global High Throughput Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global High Throughput Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Personalized Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Personalized Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Personalized Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Biomarker Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Biomarker Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Biomarker Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Genetic Profiling Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Genetic Profiling Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Genetic Profiling Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Point Of Care Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Point Of Care Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Point Of Care Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Microfluidic Chip in Biomedical Field Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 156. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. Global Point Of Care Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Global Point Of Care Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. Global Point Of Care Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. Global Microfluidic Chip in Biomedical Field Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by High Throughput, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Low To Moderate Throughput, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Technology, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Continuous Flow, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Digital Microfluidics, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Droplet-Based, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Material, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Glass, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Paper, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 175. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Silicon, 2017-2032 (USD Million)
TABLE 176. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Lab On A Chip, 2017-2032 (USD Million)
TABLE 178. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 180. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 181. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 182. Asia-Pacific Microfluidic Chip in Biomedical Field Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. North America Microfluidic Chip in Biomedical Field Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. North America Microfluidic Chip in Biomedical Field Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 185. North America Microfluidic Chip in Biomedical Field Market Size, by High Throughput, 2017-2032 (USD Million)
TABLE 186. North America Microfluidic Chip in Biomedical Field Market Size, by Low To Moderate Throughput, 2017-2032 (USD Million)
TABLE 187. North America Microfluidic Chip in Biomedical Field Market Size, by Technology, 2017-2032 (USD Million)
TABLE 188. North America Microfluidic Chip in Biomedical Field Market Size, by Continuous Flow, 2017-2032 (USD Million)
TABLE 189. North America Microfluidic Chip in Biomedical Field Market Size, by Digital Microfluidics, 2017-2032 (USD Million)
TABLE 190. North America Microfluidic Chip in Biomedical Field Market Size, by Droplet-Based, 2017-2032 (USD Million)
TABLE 191. North America Microfluidic Chip in Biomedical Field Market Size, by Material, 2017-2032 (USD Million)
TABLE 192. North America Microfluidic Chip in Biomedical Field Market Size, by Glass, 2017-2032 (USD Million)
TABLE 193. North America Microfluidic Chip in Biomedical Field Market Size, by Paper, 2017-2032 (USD Million)
TABLE 194. North America Microfluidic Chip in Biomedical Field Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 195. North America Microfluidic Chip in Biomedical Field Market Size, by Silicon, 2017-2032 (USD Million)
TABLE 196. North America Microfluidic Chip in Biomedical Field Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. North America Microfluidic Chip in Biomedical Field Market Size, by Lab On A Chip, 2017-2032 (USD Million)
TABLE 198. North America Microfluidic Chip in Biomedical Field Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. North America Microfluidic Chip in Biomedical Field Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 200. North America Microfluidic Chip in Biomedical Field Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 201. North America Microfluidic Chip in Biomedical Field Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 202. North America Microfluidic Chip in Biomedical Field Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Latin America Microfluidic Chip in Biomedical Field Market Size, by Region, 2017-2032 (USD Million)
TABLE 204. Latin America Microfluidic Chip in Biomedical Field Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 205. Latin America Microfluidic Chip in Biomedical Field Market Size, by High Throughput, 2017-2032 (USD Million)
TABLE 206. Latin America Microfluidic Chip in Biomedical Field Market Size, by Low To Moderate Throughput, 2017-2032 (USD Million)
TABLE 207. Latin America Microfluidic Chip in Biomedical Field Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. Latin America Microfluidic Chip in Biomedical Field Market Size, by Continuous Flow, 2017-2032 (USD Million)
TABLE 209. Latin America Microfluidic Chip in Biomedical Field Market Size, by Digital Microfluidics, 2017-2032 (USD Million)
TABLE 210. Latin America Microfluidic Chip in Biomedical Field Market Size, by Droplet-Based, 2017-2032 (USD Million)
TABLE 211. Latin America Microfluidic Chip in Biomedical Field Market Size, by Material, 2017-2032 (USD Million)
TABLE 212. Latin America Microfluidic Chip in Biomedical Field Market Size, by Glass, 2017-2032 (USD Million)
TABLE 213. Latin America Microfluidic Chip in Biomedical Field Market Size, by Paper, 2017-2032 (USD Million)
TABLE 214. Latin America Microfluidic Chip in Biomedical Field Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 215. Latin America Microfluidic Chip in Biomedical Field Market Size, by Silicon, 2017-2032 (USD Million)
TABLE 216. Latin America Microfluidic Chip in Biomedical Field Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. Latin America Microfluidic Chip in Biomedical Field Market Size, by Lab On A Chip, 2017-2032 (USD Million)
TABLE 218. Latin America Microfluidic Chip in Biomedical Field Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. Latin America Microfluidic Chip in Biomedical Field Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 220. Latin America Microfluidic Chip in Biomedical Field Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 221. Latin America Microfluidic Chip in Biomedical Field Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 222. Latin America Microfluidic Chip in Biomedical Field Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Europe Microfluidic Chip in Biomedical Field Market Size, by Region, 2017-2032 (USD Million)
TABLE 224. Europe Microfluidic Chip in Biomedical Field Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 225. Europe Microfluidic Chip in Biomedical Field Market Size, by High Throughput, 2017-2032 (USD Million)
TABLE 226. Europe Microfluidic Chip in Biomedical Field Market Size, by Low To Moderate Throughput, 2017-2032 (USD Million)
TABLE 227. Europe Microfluidic Chip in Biomedical Field Market Size, by Technology, 2017-2032 (USD Million)
TABLE 228. Europe Microfluidic Chip in Biomedical Field Market Size, by Continuous Flow, 2017-2032 (USD Million)
TABLE 229. Europe Microfluidic Chip in Biomedical Field Market Size, by Digital Microfluidics, 2017-2032 (USD Million)
TABLE 230. Europe Microfluidic Chip in Biomedical Field Market Size, by Droplet-Based, 2017-2032 (USD Million)
TABLE 231. Europe Microfluidic Chip in Biomedical Field Market Size, by Material, 2017-2032 (USD Million)
TABLE 232. Europe Microfluidic Chip in Biomedical Field Market Size, by Glass, 2017-2032 (USD Million)
TABLE 233. Europe Microfluidic Chip in Biomedical Field Market Size, by Paper, 2017-2032 (USD Million)
TABLE 234. Europe Microfluidic Chip in Biomedical Field Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 235. Europe Microfluidic Chip in Biomedical Field Market Size, by Silicon, 2017-2032 (USD Million)
TABLE 236. Europe Microfluidic Chip in Biomedical Field Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 237. Europe Microfluidic Chip in Biomedical Field Market Size, by Lab On A Chip, 2017-2032 (USD Million)
TABLE 238. Europe Microfluidic Chip in Biomedical Field Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. Europe Microfluidic Chip in Biomedical Field Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 240. Europe Microfluidic Chip in Biomedical Field Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 241. Europe Microfluidic Chip in Biomedical Field Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 242. Europe Microfluidic Chip in Biomedical Field Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Middle East Microfluidic Chip in Biomedical Field Market Size, by Region, 2017-2032 (USD Million)
TABLE 244. Middle East Microfluidic Chip in Biomedical Field Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 245. Middle East Microfluidic Chip in Biomedical Field Market Size, by High Throughput, 2017-2032 (USD Million)
TABLE 246. Middle East Microfluidic Chip in Biomedical Field Market Size, by Low To Moderate Throughput, 2017-2032 (USD Million)
TABLE 247. Middle East Microfluidic Chip in Biomedical Field Market Size, by Technology, 2017-2032 (USD Million)
TABLE 248. Middle East Microfluidic Chip in Biomedical Field Market Size, by Continuous Flow, 2017-2032 (USD Million)
TABLE 249. Middle East Microfluidic Chip in Biomedical Field Market Size, by Digital Microfluidics, 2017-2032 (USD Million)
TABLE 250. Middle East Microfluidic Chip in Biomedical Field Market Size, by Droplet-Based, 2017-2032 (USD Million)
TABLE 251. Middle East Microfluidic Chip in Biomedical Field Market Size, by Material, 2017-2032 (USD Million)
TABLE 252. Middle East Microfluidic Chip in Biomedical Field Market Size, by Glass, 2017-2032 (USD Million)
TABLE 253. Middle East Microfluidic Chip in Biomedical Field Market Size, by Paper, 2017-2032 (USD Million)
TABLE 254. Middle East Microfluidic Chip in Biomedical Field Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 255. Middle East Microfluidic Chip in Biomedical Field Market Size, by Silicon, 2017-2032 (USD Million)
TABLE 256. Middle East Microfluidic Chip in Biomedical Field Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 257. Middle East Microfluidic Chip in Biomedical Field Market Size, by Lab On A Chip, 2017-2032 (USD Million)
TABLE 258. Middle East Microfluidic Chip in Biomedical Field Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. Middle East Microfluidic Chip in Biomedical Field Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 260. Middle East Microfluidic Chip in Biomedical Field Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 261. Middle East Microfluidic Chip in Biomedical Field Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 262. Middle East Microfluidic Chip in Biomedical Field Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Africa Microfluidic Chip in Biomedical Field Market Size, by Region, 2017-2032 (USD Million)
TABLE 264. Africa Microfluidic Chip in Biomedical Field Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 265. Africa Microfluidic Chip in Biomedical Field Market Size, by High Throughput, 2017-2032 (USD Million)
TABLE 266. Africa Microfluidic Chip in Biomedical Field Market Size, by Low To Moderate Throughput, 2017-2032 (USD Million)
TABLE 267. Africa Microfluidic Chip in Biomedical Field Market Size, by Technology, 2017-2032 (USD Million)
TABLE 268. Africa Microfluidic Chip in Biomedical Field Market Size, by Continuous Flow, 2017-2032 (USD Million)
TABLE 269. Africa Microfluidic Chip in Biomedical Field Market Size, by Digital Microfluidics, 2017-2032 (USD Million)
TABLE 270. Africa Microfluidic Chip in Biomedical Field Market Size, by Droplet-Based, 2017-2032 (USD Million)
TABLE 271. Africa Microfluidic Chip in Biomedical Field Market Size, by Material, 2017-2032 (USD Million)
TABLE 272. Africa Microfluidic Chip in Biomedical Field Market Size, by Glass, 2017-2032 (USD Million)
TABLE 273. Africa Microfluidic Chip in Biomedical Field Market Size, by Paper, 2017-2032 (USD Million)
TABLE 274. Africa Microfluidic Chip in Biomedical Field Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 275. Africa Microfluidic Chip in Biomedical Field Market Size, by Silicon, 2017-2032 (USD Million)
TABLE 276. Africa Microfluidic Chip in Biomedical Field Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 277. Africa Microfluidic Chip in Biomedical Field Market Size, by Lab On A Chip, 2017-2032 (USD Million)
TABLE 278. Africa Microfluidic Chip in Biomedical Field Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. Africa Microfluidic Chip in Biomedical Field Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 280. Africa Microfluidic Chip in Biomedical Field Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 281. Africa Microfluidic Chip in Biomedical Field Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 282. Africa Microfluidic Chip in Biomedical Field Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. Global Microfluidic Chip in Biomedical Field Market Size, by Group, 2017-2032 (USD Million)
TABLE 284. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Group, 2017-2032 (USD Million)
TABLE 285. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 286. ASEAN Microfluidic Chip in Biomedical Field Market Size, by High Throughput, 2017-2032 (USD Million)
TABLE 287. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Low To Moderate Throughput, 2017-2032 (USD Million)
TABLE 288. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Technology, 2017-2032 (USD Million)
TABLE 289. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Continuous Flow, 2017-2032 (USD Million)
TABLE 290. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Digital Microfluidics, 2017-2032 (USD Million)
TABLE 291. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Droplet-Based, 2017-2032 (USD Million)
TABLE 292. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Material, 2017-2032 (USD Million)
TABLE 293. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Glass, 2017-2032 (USD Million)
TABLE 294. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Paper, 2017-2032 (USD Million)
TABLE 295. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 296. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Silicon, 2017-2032 (USD Million)
TABLE 297. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 298. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Lab On A Chip, 2017-2032 (USD Million)
TABLE 299. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 301. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 302. ASEAN Microfluidic Chip in Biomedical Field Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 303. ASEAN Microfluidic Chip in Biomedical Field Market Size, by End User, 2017-2032 (USD Million)
TABLE 304. GCC Microfluidic Chip in Biomedical Field Market Size, by Group, 2017-2032 (USD Million)
TABLE 305. GCC Microfluidic Chip in Biomedical Field Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 306. GCC Microfluidic Chip in Biomedical Field Market Size, by High Throughput, 2017-2032 (USD Million)
TABLE 307. GCC Microfluidic Chip in Biomedical Field Market Size, by Low To Moderate Throughput, 2017-2032 (USD Million)
TABLE 308. GCC Microfluidic Chip in Biomedical Field Market Size, by Technology, 2017-2032 (USD Million)
TABLE 309. GCC Microfluidic Chip in Biomedical Field Market Size, by Continuous Flow, 2017-2032 (USD Million)
TABLE 310. GCC Microfluidic Chip in Biomedical Field Market Size, by Digital Microfluidics, 2017-2032 (USD Million)
TABLE 311. GCC Microfluidic Chip in Biomedical Field Market Size, by Droplet-Based, 2017-2032 (USD Million)
TABLE 312. GCC Microfluidic Chip in Biomedical Field Market Size, by Material, 2017-2032 (USD Million)
TABLE 313. GCC Microfluidic Chip in Biomedical Field Market Size, by Glass, 2017-2032 (USD Million)
TABLE 314. GCC Microfluidic Chip in Biomedical Field Market Size, by Paper, 2017-2032 (USD Million)
TABLE 315. GCC Microfluidic Chip in Biomedical Field Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 316. GCC Microfluidic Chip in Biomedical Field Market Size, by Silicon, 2017-2032 (USD Million)
TABLE 317. GCC Microfluidic Chip in Biomedical Field Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 318. GCC Microfluidic Chip in Biomedical Field Market Size, by Lab On A Chip, 2017-2032 (USD Million)
TABLE 319. GCC Microfluidic Chip in Biomedical Field Market Size, by Application, 2017-2032 (USD Million)
TABLE 320. GCC Microfluidic Chip in Biomedical Field Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 321. GCC Microfluidic Chip in Biomedical Field Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 322. GCC Microfluidic Chip in Biomedical Field Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 323. GCC Microfluidic Chip in Biomedical Field Market Size, by End User, 2017-2032 (USD Million)
TABLE 324. European Union Microfluidic Chip in Biomedical Field Market Size, by Group, 2017-2032 (USD Million)
TABLE 325. European Union Microfluidic Chip in Biomedical Field Market Size, by Throughput, 2017-2032 (USD Million)
TABLE 326. European Union Microfluidic Chip in Biomedical Field Market Size, by High Throughput, 2017-2032 (USD Million)
TABLE 327. European Union Microfluidic Chip in Biomedical Field Market Size, by Low To Moderate Throughput, 2017-2032 (USD Million)
TABLE 328. European Union Microfluidic Chip in Biomedical Field Market Size, by Technology, 2017-2032 (USD Million)
TABLE 329. European Union Microfluidic Chip in Biomedical Field Market Size, by Continuous Flow, 2017-2032 (USD Million)
TABLE 330. European Union Microfluidic Chip in Biomedical Field Market Size, by Digital Microfluidics, 2017-2032 (USD Million)
TABLE 331. European Union Microfluidic Chip in Biomedical Field Market Size, by Droplet-Based, 2017-2032 (USD Million)
TABLE 332. European Union Microfluidic Chip in Biomedical Field Market Size, by Material, 2017-2032 (USD Million)
TABLE 333. European Union Microfluidic Chip in Biomedical Field Market Size, by Glass, 2017-2032 (USD Million)
TABLE 334. European Union Microfluidic Chip in Biomedical Field Market Size, by Paper, 2017-2032 (USD Million)
TABLE 335. European Union Microfluidic Chip in Biomedical Field Market Size, by Polymer, 2017-2032 (USD Million)
TABLE 336. European Union

Companies Mentioned

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Aline Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cherry Biotech SAS
  • Danaher Corporation
  • Dolomite Microfluidics
  • Elveflow (Elvesys)
  • Emulate, Inc.
  • Fluidic Analytics Ltd.
  • Fluidigm Corporation
  • Illumina, Inc.
  • Merck KGaA
  • Micronit Microtechnologies B.V.
  • Mimetas B.V.
  • Nanostring Technologies, Inc.
  • PerkinElmer, Inc.
  • Roche Diagnostics International AG
  • Sphere Fluidics Limited
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
  • Zymergen Inc.

Related Topics

Related Reports

Microfluidic Device Systems - Global Strategic Business Report - Product Image

Microfluidic Device Systems - Global Strategic Business Report

  • Report
  • 212 Pages
  • Global
From
Microfluidic Droplet Chip Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Microfluidic Droplet Chip Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 161 Pages
  • Global
From
Microfluidics Market - Global Forecast 2026-2032 - Product Image

Microfluidics Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Microfluidic Control Device Market Report: Strategic Insights, Technology Trends, and Industry Forecasts - Product Image

Microfluidic Control Device Market Report: Strategic Insights, Technology Trends, and Industry Forecasts

  • Report
  • 168 Pages
  • Global
From
Microfluidics Market by Product, Material, Application, End User - Global Forecast to 2030 - Product Image

Microfluidics Market by Product, Material, Application, End User - Global Forecast to 2030

  • Report
  • 326 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.